nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A4—type 2 diabetes mellitus	0.157	1	CbGaD
Fentanyl—Quinapril—Ramipril—type 2 diabetes mellitus	0.117	0.512	CrCrCtD
Fentanyl—Benazepril—Ramipril—type 2 diabetes mellitus	0.112	0.488	CrCrCtD
Fentanyl—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0339	0.093	CbGbCtD
Fentanyl—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0339	0.093	CbGbCtD
Fentanyl—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0339	0.093	CbGbCtD
Fentanyl—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0302	0.0829	CbGbCtD
Fentanyl—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0254	0.0698	CbGbCtD
Fentanyl—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0219	0.0599	CbGbCtD
Fentanyl—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0203	0.0557	CbGbCtD
Fentanyl—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0181	0.0496	CbGbCtD
Fentanyl—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0166	0.0454	CbGbCtD
Fentanyl—CYP3A5—Losartan—type 2 diabetes mellitus	0.0157	0.0431	CbGbCtD
Fentanyl—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.015	0.0412	CbGbCtD
Fentanyl—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0145	0.0397	CbGbCtD
Fentanyl—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0131	0.0359	CbGbCtD
Fentanyl—ABCB1—Glyburide—type 2 diabetes mellitus	0.0112	0.0307	CbGbCtD
Fentanyl—ABCB1—Losartan—type 2 diabetes mellitus	0.0102	0.028	CbGbCtD
Fentanyl—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00992	0.0272	CbGbCtD
Fentanyl—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00951	0.0261	CbGbCtD
Fentanyl—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00951	0.0261	CbGbCtD
Fentanyl—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.009	0.0247	CbGbCtD
Fentanyl—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0067	0.0184	CbGbCtD
Fentanyl—CYP3A4—Losartan—type 2 diabetes mellitus	0.00613	0.0168	CbGbCtD
Fentanyl—Bepridil—KCNQ1—type 2 diabetes mellitus	0.000535	0.143	CrCbGaD
Fentanyl—Aprindine—CALM1—type 2 diabetes mellitus	0.000413	0.111	CrCbGaD
Fentanyl—Bepridil—CALM1—type 2 diabetes mellitus	0.000255	0.0683	CrCbGaD
Fentanyl—Benazepril—MTHFR—type 2 diabetes mellitus	0.00023	0.0615	CrCbGaD
Fentanyl—Loperamide—CALM1—type 2 diabetes mellitus	0.000226	0.0605	CrCbGaD
Fentanyl—Quinapril—ACE—type 2 diabetes mellitus	0.000215	0.0576	CrCbGaD
Fentanyl—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.000199	0.0532	CrCbGaD
Fentanyl—Benazepril—ACE—type 2 diabetes mellitus	0.000187	0.0501	CrCbGaD
Fentanyl—Sufentanil—CYP3A4—type 2 diabetes mellitus	0.000143	0.0384	CrCbGaD
Fentanyl—Alfentanil—CYP3A4—type 2 diabetes mellitus	0.000133	0.0357	CrCbGaD
Fentanyl—Alfentanil—ALB—type 2 diabetes mellitus	0.000116	0.0311	CrCbGaD
Fentanyl—Astemizole—CYP3A4—type 2 diabetes mellitus	0.000104	0.0278	CrCbGaD
Fentanyl—Benzphetamine—ADRA2A—type 2 diabetes mellitus	9.41e-05	0.0252	CrCbGaD
Fentanyl—Propafenone—CYP1A2—type 2 diabetes mellitus	9e-05	0.0241	CrCbGaD
Fentanyl—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	8.99e-05	0.0241	CrCbGaD
Fentanyl—Darifenacin—CYP3A4—type 2 diabetes mellitus	7.6e-05	0.0203	CrCbGaD
Fentanyl—Modafinil—CYP1A2—type 2 diabetes mellitus	7.54e-05	0.0202	CrCbGaD
Fentanyl—Phenylbutazone—CYP3A4—type 2 diabetes mellitus	6.37e-05	0.0171	CrCbGaD
Fentanyl—Phenylbutazone—PTGS2—type 2 diabetes mellitus	6.24e-05	0.0167	CrCbGaD
Fentanyl—Propafenone—CYP3A4—type 2 diabetes mellitus	5.96e-05	0.0159	CrCbGaD
Fentanyl—Thrombocytopenia—Metformin—type 2 diabetes mellitus	5.29e-05	0.000274	CcSEcCtD
Fentanyl—Dyspnoea—Valsartan—type 2 diabetes mellitus	5.29e-05	0.000274	CcSEcCtD
Fentanyl—Vertigo—Losartan—type 2 diabetes mellitus	5.28e-05	0.000274	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000274	CcSEcCtD
Fentanyl—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	5.28e-05	0.000274	CcSEcCtD
Fentanyl—Somnolence—Valsartan—type 2 diabetes mellitus	5.28e-05	0.000273	CcSEcCtD
Fentanyl—Syncope—Losartan—type 2 diabetes mellitus	5.28e-05	0.000273	CcSEcCtD
Fentanyl—Paraesthesia—Orlistat—type 2 diabetes mellitus	5.27e-05	0.000273	CcSEcCtD
Fentanyl—Leukopenia—Losartan—type 2 diabetes mellitus	5.27e-05	0.000273	CcSEcCtD
Fentanyl—Discomfort—Irbesartan—type 2 diabetes mellitus	5.26e-05	0.000272	CcSEcCtD
Fentanyl—Skin disorder—Metformin—type 2 diabetes mellitus	5.25e-05	0.000272	CcSEcCtD
Fentanyl—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	5.24e-05	0.014	CrCbGaD
Fentanyl—Immune system disorder—Ramipril—type 2 diabetes mellitus	5.23e-05	0.000271	CcSEcCtD
Fentanyl—Hyperhidrosis—Metformin—type 2 diabetes mellitus	5.23e-05	0.000271	CcSEcCtD
Fentanyl—Dyspepsia—Valsartan—type 2 diabetes mellitus	5.23e-05	0.000271	CcSEcCtD
Fentanyl—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	5.22e-05	0.00027	CcSEcCtD
Fentanyl—Dizziness—Bromocriptine—type 2 diabetes mellitus	5.2e-05	0.00027	CcSEcCtD
Fentanyl—Dry mouth—Irbesartan—type 2 diabetes mellitus	5.2e-05	0.000269	CcSEcCtD
Fentanyl—Palpitations—Losartan—type 2 diabetes mellitus	5.2e-05	0.000269	CcSEcCtD
Fentanyl—Nausea—Glimepiride—type 2 diabetes mellitus	5.18e-05	0.000268	CcSEcCtD
Fentanyl—Arrhythmia—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000268	CcSEcCtD
Fentanyl—Loss of consciousness—Losartan—type 2 diabetes mellitus	5.17e-05	0.000268	CcSEcCtD
Fentanyl—Nausea—Sitagliptin—type 2 diabetes mellitus	5.17e-05	0.000268	CcSEcCtD
Fentanyl—Dyspepsia—Orlistat—type 2 diabetes mellitus	5.16e-05	0.000267	CcSEcCtD
Fentanyl—Asthenia—Glyburide—type 2 diabetes mellitus	5.16e-05	0.000267	CcSEcCtD
Fentanyl—Decreased appetite—Valsartan—type 2 diabetes mellitus	5.16e-05	0.000267	CcSEcCtD
Fentanyl—Anorexia—Metformin—type 2 diabetes mellitus	5.15e-05	0.000267	CcSEcCtD
Fentanyl—Cough—Losartan—type 2 diabetes mellitus	5.13e-05	0.000266	CcSEcCtD
Fentanyl—Urticaria—Gliclazide—type 2 diabetes mellitus	5.13e-05	0.000266	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000265	CcSEcCtD
Fentanyl—Alopecia—Ramipril—type 2 diabetes mellitus	5.12e-05	0.000265	CcSEcCtD
Fentanyl—Fatigue—Valsartan—type 2 diabetes mellitus	5.12e-05	0.000265	CcSEcCtD
Fentanyl—Abdominal pain—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.000264	CcSEcCtD
Fentanyl—Body temperature increased—Gliclazide—type 2 diabetes mellitus	5.11e-05	0.000264	CcSEcCtD
Fentanyl—Oedema—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000264	CcSEcCtD
Fentanyl—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	5.1e-05	0.000264	CcSEcCtD
Fentanyl—Decreased appetite—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000264	CcSEcCtD
Fentanyl—Pruritus—Glyburide—type 2 diabetes mellitus	5.09e-05	0.000264	CcSEcCtD
Fentanyl—Mental disorder—Ramipril—type 2 diabetes mellitus	5.08e-05	0.000263	CcSEcCtD
Fentanyl—Constipation—Valsartan—type 2 diabetes mellitus	5.08e-05	0.000263	CcSEcCtD
Fentanyl—Infection—Irbesartan—type 2 diabetes mellitus	5.07e-05	0.000262	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000262	CcSEcCtD
Fentanyl—Methadone—CYP1A2—type 2 diabetes mellitus	5.06e-05	0.0135	CrCbGaD
Fentanyl—Fatigue—Orlistat—type 2 diabetes mellitus	5.06e-05	0.000262	CcSEcCtD
Fentanyl—Hypotension—Metformin—type 2 diabetes mellitus	5.05e-05	0.000262	CcSEcCtD
Fentanyl—Erythema—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000261	CcSEcCtD
Fentanyl—Malnutrition—Ramipril—type 2 diabetes mellitus	5.04e-05	0.000261	CcSEcCtD
Fentanyl—Shock—Irbesartan—type 2 diabetes mellitus	5.02e-05	0.00026	CcSEcCtD
Fentanyl—Pain—Orlistat—type 2 diabetes mellitus	5.02e-05	0.00026	CcSEcCtD
Fentanyl—Myalgia—Losartan—type 2 diabetes mellitus	5.01e-05	0.000259	CcSEcCtD
Fentanyl—Arthralgia—Losartan—type 2 diabetes mellitus	5.01e-05	0.000259	CcSEcCtD
Fentanyl—Chest pain—Losartan—type 2 diabetes mellitus	5.01e-05	0.000259	CcSEcCtD
Fentanyl—Vomiting—Bromocriptine—type 2 diabetes mellitus	5e-05	0.000259	CcSEcCtD
Fentanyl—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	5e-05	0.000259	CcSEcCtD
Fentanyl—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.99e-05	0.000259	CcSEcCtD
Fentanyl—Modafinil—CYP3A4—type 2 diabetes mellitus	4.99e-05	0.0134	CrCbGaD
Fentanyl—Anxiety—Losartan—type 2 diabetes mellitus	4.99e-05	0.000258	CcSEcCtD
Fentanyl—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000258	CcSEcCtD
Fentanyl—Rash—Bromocriptine—type 2 diabetes mellitus	4.96e-05	0.000257	CcSEcCtD
Fentanyl—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.96e-05	0.000257	CcSEcCtD
Fentanyl—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.95e-05	0.000257	CcSEcCtD
Fentanyl—Tension—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000256	CcSEcCtD
Fentanyl—Discomfort—Losartan—type 2 diabetes mellitus	4.95e-05	0.000256	CcSEcCtD
Fentanyl—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.94e-05	0.000256	CcSEcCtD
Fentanyl—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	4.94e-05	0.0132	CrCbGaD
Fentanyl—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000255	CcSEcCtD
Fentanyl—Headache—Bromocriptine—type 2 diabetes mellitus	4.93e-05	0.000255	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.92e-05	0.000255	CcSEcCtD
Fentanyl—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.92e-05	0.000255	CcSEcCtD
Fentanyl—Nervousness—Ramipril—type 2 diabetes mellitus	4.9e-05	0.000254	CcSEcCtD
Fentanyl—Dry mouth—Losartan—type 2 diabetes mellitus	4.9e-05	0.000254	CcSEcCtD
Fentanyl—Anorexia—Irbesartan—type 2 diabetes mellitus	4.86e-05	0.000252	CcSEcCtD
Fentanyl—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.85e-05	0.000251	CcSEcCtD
Fentanyl—Paraesthesia—Metformin—type 2 diabetes mellitus	4.85e-05	0.000251	CcSEcCtD
Fentanyl—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.85e-05	0.000251	CcSEcCtD
Fentanyl—Confusional state—Losartan—type 2 diabetes mellitus	4.84e-05	0.000251	CcSEcCtD
Fentanyl—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.83e-05	0.00025	CcSEcCtD
Fentanyl—Dyspnoea—Metformin—type 2 diabetes mellitus	4.82e-05	0.00025	CcSEcCtD
Fentanyl—Somnolence—Metformin—type 2 diabetes mellitus	4.81e-05	0.000249	CcSEcCtD
Fentanyl—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.8e-05	0.000249	CcSEcCtD
Fentanyl—Oedema—Losartan—type 2 diabetes mellitus	4.8e-05	0.000249	CcSEcCtD
Fentanyl—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.8e-05	0.000248	CcSEcCtD
Fentanyl—Infection—Losartan—type 2 diabetes mellitus	4.77e-05	0.000247	CcSEcCtD
Fentanyl—Hypotension—Irbesartan—type 2 diabetes mellitus	4.77e-05	0.000247	CcSEcCtD
Fentanyl—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.76e-05	0.000246	CcSEcCtD
Fentanyl—Dyspepsia—Metformin—type 2 diabetes mellitus	4.76e-05	0.000246	CcSEcCtD
Fentanyl—Tremor—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000245	CcSEcCtD
Fentanyl—Shock—Losartan—type 2 diabetes mellitus	4.72e-05	0.000245	CcSEcCtD
Fentanyl—Urticaria—Valsartan—type 2 diabetes mellitus	4.72e-05	0.000244	CcSEcCtD
Fentanyl—Nervous system disorder—Losartan—type 2 diabetes mellitus	4.71e-05	0.000244	CcSEcCtD
Fentanyl—Loperamide—CYP3A4—type 2 diabetes mellitus	4.7e-05	0.0126	CrCbGaD
Fentanyl—Thrombocytopenia—Losartan—type 2 diabetes mellitus	4.7e-05	0.000243	CcSEcCtD
Fentanyl—Decreased appetite—Metformin—type 2 diabetes mellitus	4.7e-05	0.000243	CcSEcCtD
Fentanyl—Abdominal pain—Valsartan—type 2 diabetes mellitus	4.69e-05	0.000243	CcSEcCtD
Fentanyl—Tachycardia—Losartan—type 2 diabetes mellitus	4.69e-05	0.000243	CcSEcCtD
Fentanyl—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	4.68e-05	0.000242	CcSEcCtD
Fentanyl—Nausea—Bromocriptine—type 2 diabetes mellitus	4.68e-05	0.000242	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	4.67e-05	0.000242	CcSEcCtD
Fentanyl—Fatigue—Metformin—type 2 diabetes mellitus	4.66e-05	0.000241	CcSEcCtD
Fentanyl—Urticaria—Orlistat—type 2 diabetes mellitus	4.66e-05	0.000241	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	4.65e-05	0.000241	CcSEcCtD
Fentanyl—Hyperhidrosis—Losartan—type 2 diabetes mellitus	4.64e-05	0.00024	CcSEcCtD
Fentanyl—Body temperature increased—Orlistat—type 2 diabetes mellitus	4.64e-05	0.00024	CcSEcCtD
Fentanyl—Abdominal pain—Orlistat—type 2 diabetes mellitus	4.64e-05	0.00024	CcSEcCtD
Fentanyl—Asthenia—Gliclazide—type 2 diabetes mellitus	4.64e-05	0.00024	CcSEcCtD
Fentanyl—Agitation—Ramipril—type 2 diabetes mellitus	4.64e-05	0.00024	CcSEcCtD
Fentanyl—Constipation—Metformin—type 2 diabetes mellitus	4.62e-05	0.000239	CcSEcCtD
Fentanyl—Paraesthesia—Irbesartan—type 2 diabetes mellitus	4.58e-05	0.000237	CcSEcCtD
Fentanyl—Anorexia—Losartan—type 2 diabetes mellitus	4.58e-05	0.000237	CcSEcCtD
Fentanyl—Vomiting—Glyburide—type 2 diabetes mellitus	4.57e-05	0.000237	CcSEcCtD
Fentanyl—Pruritus—Gliclazide—type 2 diabetes mellitus	4.57e-05	0.000237	CcSEcCtD
Fentanyl—Malaise—Ramipril—type 2 diabetes mellitus	4.55e-05	0.000236	CcSEcCtD
Fentanyl—Dyspnoea—Irbesartan—type 2 diabetes mellitus	4.55e-05	0.000236	CcSEcCtD
Fentanyl—Rash—Glyburide—type 2 diabetes mellitus	4.54e-05	0.000235	CcSEcCtD
Fentanyl—Somnolence—Irbesartan—type 2 diabetes mellitus	4.54e-05	0.000235	CcSEcCtD
Fentanyl—Dermatitis—Glyburide—type 2 diabetes mellitus	4.53e-05	0.000235	CcSEcCtD
Fentanyl—Vertigo—Ramipril—type 2 diabetes mellitus	4.53e-05	0.000235	CcSEcCtD
Fentanyl—Syncope—Ramipril—type 2 diabetes mellitus	4.52e-05	0.000234	CcSEcCtD
Fentanyl—Leukopenia—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000234	CcSEcCtD
Fentanyl—Headache—Glyburide—type 2 diabetes mellitus	4.51e-05	0.000233	CcSEcCtD
Fentanyl—Dyspepsia—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000233	CcSEcCtD
Fentanyl—Hypotension—Losartan—type 2 diabetes mellitus	4.49e-05	0.000232	CcSEcCtD
Fentanyl—Palpitations—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000231	CcSEcCtD
Fentanyl—Feeling abnormal—Metformin—type 2 diabetes mellitus	4.45e-05	0.000231	CcSEcCtD
Fentanyl—Decreased appetite—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.00023	CcSEcCtD
Fentanyl—Loss of consciousness—Ramipril—type 2 diabetes mellitus	4.43e-05	0.00023	CcSEcCtD
Fentanyl—Diarrhoea—Gliclazide—type 2 diabetes mellitus	4.42e-05	0.000229	CcSEcCtD
Fentanyl—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	4.42e-05	0.000229	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000228	CcSEcCtD
Fentanyl—Cough—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000228	CcSEcCtD
Fentanyl—Fatigue—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000228	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	4.37e-05	0.000226	CcSEcCtD
Fentanyl—Hypersensitivity—Valsartan—type 2 diabetes mellitus	4.37e-05	0.000226	CcSEcCtD
Fentanyl—Convulsion—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000226	CcSEcCtD
Fentanyl—Pain—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000226	CcSEcCtD
Fentanyl—Constipation—Irbesartan—type 2 diabetes mellitus	4.36e-05	0.000226	CcSEcCtD
Fentanyl—Insomnia—Losartan—type 2 diabetes mellitus	4.34e-05	0.000225	CcSEcCtD
Fentanyl—Benzphetamine—CYP3A4—type 2 diabetes mellitus	4.33e-05	0.0116	CrCbGaD
Fentanyl—Hypersensitivity—Orlistat—type 2 diabetes mellitus	4.32e-05	0.000224	CcSEcCtD
Fentanyl—Paraesthesia—Losartan—type 2 diabetes mellitus	4.31e-05	0.000223	CcSEcCtD
Fentanyl—Urticaria—Metformin—type 2 diabetes mellitus	4.29e-05	0.000222	CcSEcCtD
Fentanyl—Chest pain—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000222	CcSEcCtD
Fentanyl—Arthralgia—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000222	CcSEcCtD
Fentanyl—Myalgia—Ramipril—type 2 diabetes mellitus	4.29e-05	0.000222	CcSEcCtD
Fentanyl—Dyspnoea—Losartan—type 2 diabetes mellitus	4.28e-05	0.000222	CcSEcCtD
Fentanyl—Anxiety—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000222	CcSEcCtD
Fentanyl—Nausea—Glyburide—type 2 diabetes mellitus	4.27e-05	0.000221	CcSEcCtD
Fentanyl—Abdominal pain—Metformin—type 2 diabetes mellitus	4.27e-05	0.000221	CcSEcCtD
Fentanyl—Dizziness—Gliclazide—type 2 diabetes mellitus	4.27e-05	0.000221	CcSEcCtD
Fentanyl—Somnolence—Losartan—type 2 diabetes mellitus	4.27e-05	0.000221	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000221	CcSEcCtD
Fentanyl—Asthenia—Valsartan—type 2 diabetes mellitus	4.26e-05	0.000221	CcSEcCtD
Fentanyl—Discomfort—Ramipril—type 2 diabetes mellitus	4.24e-05	0.00022	CcSEcCtD
Fentanyl—Dyspepsia—Losartan—type 2 diabetes mellitus	4.23e-05	0.000219	CcSEcCtD
Fentanyl—Asthenia—Orlistat—type 2 diabetes mellitus	4.21e-05	0.000218	CcSEcCtD
Fentanyl—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	4.2e-05	0.000218	CcSEcCtD
Fentanyl—Pruritus—Valsartan—type 2 diabetes mellitus	4.2e-05	0.000217	CcSEcCtD
Fentanyl—Dry mouth—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000217	CcSEcCtD
Fentanyl—Decreased appetite—Losartan—type 2 diabetes mellitus	4.17e-05	0.000216	CcSEcCtD
Fentanyl—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	4.17e-05	0.000216	CcSEcCtD
Fentanyl—Confusional state—Ramipril—type 2 diabetes mellitus	4.15e-05	0.000215	CcSEcCtD
Fentanyl—Pruritus—Orlistat—type 2 diabetes mellitus	4.15e-05	0.000215	CcSEcCtD
Fentanyl—Fatigue—Losartan—type 2 diabetes mellitus	4.14e-05	0.000214	CcSEcCtD
Fentanyl—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	4.14e-05	0.0111	CrCbGaD
Fentanyl—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000213	CcSEcCtD
Fentanyl—Oedema—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000213	CcSEcCtD
Fentanyl—Vomiting—Gliclazide—type 2 diabetes mellitus	4.11e-05	0.000213	CcSEcCtD
Fentanyl—Constipation—Losartan—type 2 diabetes mellitus	4.11e-05	0.000213	CcSEcCtD
Fentanyl—Pain—Losartan—type 2 diabetes mellitus	4.11e-05	0.000213	CcSEcCtD
Fentanyl—Rash—Gliclazide—type 2 diabetes mellitus	4.07e-05	0.000211	CcSEcCtD
Fentanyl—Dermatitis—Gliclazide—type 2 diabetes mellitus	4.07e-05	0.000211	CcSEcCtD
Fentanyl—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.06e-05	0.00021	CcSEcCtD
Fentanyl—Urticaria—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.00021	CcSEcCtD
Fentanyl—Shock—Ramipril—type 2 diabetes mellitus	4.05e-05	0.00021	CcSEcCtD
Fentanyl—Headache—Gliclazide—type 2 diabetes mellitus	4.05e-05	0.00021	CcSEcCtD
Fentanyl—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.04e-05	0.000209	CcSEcCtD
Fentanyl—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000209	CcSEcCtD
Fentanyl—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.03e-05	0.000209	CcSEcCtD
Fentanyl—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	4.03e-05	0.000209	CcSEcCtD
Fentanyl—Tachycardia—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000208	CcSEcCtD
Fentanyl—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.01e-05	0.000208	CcSEcCtD
Fentanyl—Skin disorder—Ramipril—type 2 diabetes mellitus	4e-05	0.000207	CcSEcCtD
Fentanyl—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000206	CcSEcCtD
Fentanyl—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.96e-05	0.000205	CcSEcCtD
Fentanyl—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.93e-05	0.000203	CcSEcCtD
Fentanyl—Dizziness—Valsartan—type 2 diabetes mellitus	3.93e-05	0.000203	CcSEcCtD
Fentanyl—Anorexia—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000203	CcSEcCtD
Fentanyl—Dizziness—Orlistat—type 2 diabetes mellitus	3.88e-05	0.000201	CcSEcCtD
Fentanyl—Asthenia—Metformin—type 2 diabetes mellitus	3.88e-05	0.000201	CcSEcCtD
Fentanyl—Hypotension—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000199	CcSEcCtD
Fentanyl—Nausea—Gliclazide—type 2 diabetes mellitus	3.84e-05	0.000199	CcSEcCtD
Fentanyl—Pruritus—Metformin—type 2 diabetes mellitus	3.82e-05	0.000198	CcSEcCtD
Fentanyl—Urticaria—Losartan—type 2 diabetes mellitus	3.81e-05	0.000197	CcSEcCtD
Fentanyl—Abdominal pain—Losartan—type 2 diabetes mellitus	3.8e-05	0.000197	CcSEcCtD
Fentanyl—Body temperature increased—Losartan—type 2 diabetes mellitus	3.8e-05	0.000197	CcSEcCtD
Fentanyl—Vomiting—Valsartan—type 2 diabetes mellitus	3.77e-05	0.000195	CcSEcCtD
Fentanyl—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000195	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000194	CcSEcCtD
Fentanyl—Rash—Valsartan—type 2 diabetes mellitus	3.74e-05	0.000194	CcSEcCtD
Fentanyl—Dermatitis—Valsartan—type 2 diabetes mellitus	3.74e-05	0.000194	CcSEcCtD
Fentanyl—Vomiting—Orlistat—type 2 diabetes mellitus	3.73e-05	0.000193	CcSEcCtD
Fentanyl—Insomnia—Ramipril—type 2 diabetes mellitus	3.72e-05	0.000193	CcSEcCtD
Fentanyl—Headache—Valsartan—type 2 diabetes mellitus	3.72e-05	0.000193	CcSEcCtD
Fentanyl—Diarrhoea—Metformin—type 2 diabetes mellitus	3.7e-05	0.000192	CcSEcCtD
Fentanyl—Rash—Orlistat—type 2 diabetes mellitus	3.7e-05	0.000192	CcSEcCtD
Fentanyl—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.7e-05	0.000191	CcSEcCtD
Fentanyl—Dermatitis—Orlistat—type 2 diabetes mellitus	3.69e-05	0.000191	CcSEcCtD
Fentanyl—Headache—Orlistat—type 2 diabetes mellitus	3.67e-05	0.00019	CcSEcCtD
Fentanyl—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.67e-05	0.00019	CcSEcCtD
Fentanyl—Asthenia—Irbesartan—type 2 diabetes mellitus	3.66e-05	0.00019	CcSEcCtD
Fentanyl—Somnolence—Ramipril—type 2 diabetes mellitus	3.66e-05	0.000189	CcSEcCtD
Fentanyl—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000188	CcSEcCtD
Fentanyl—Pruritus—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000187	CcSEcCtD
Fentanyl—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000185	CcSEcCtD
Fentanyl—Dizziness—Metformin—type 2 diabetes mellitus	3.57e-05	0.000185	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000184	CcSEcCtD
Fentanyl—Fatigue—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000184	CcSEcCtD
Fentanyl—Hypersensitivity—Losartan—type 2 diabetes mellitus	3.54e-05	0.000183	CcSEcCtD
Fentanyl—Nausea—Valsartan—type 2 diabetes mellitus	3.53e-05	0.000183	CcSEcCtD
Fentanyl—Constipation—Ramipril—type 2 diabetes mellitus	3.52e-05	0.000182	CcSEcCtD
Fentanyl—Diarrhoea—Irbesartan—type 2 diabetes mellitus	3.49e-05	0.000181	CcSEcCtD
Fentanyl—Nausea—Orlistat—type 2 diabetes mellitus	3.48e-05	0.00018	CcSEcCtD
Fentanyl—Asthenia—Losartan—type 2 diabetes mellitus	3.44e-05	0.000178	CcSEcCtD
Fentanyl—Vomiting—Metformin—type 2 diabetes mellitus	3.44e-05	0.000178	CcSEcCtD
Fentanyl—Rash—Metformin—type 2 diabetes mellitus	3.41e-05	0.000176	CcSEcCtD
Fentanyl—Dermatitis—Metformin—type 2 diabetes mellitus	3.41e-05	0.000176	CcSEcCtD
Fentanyl—Pruritus—Losartan—type 2 diabetes mellitus	3.4e-05	0.000176	CcSEcCtD
Fentanyl—Feeling abnormal—Ramipril—type 2 diabetes mellitus	3.39e-05	0.000176	CcSEcCtD
Fentanyl—Headache—Metformin—type 2 diabetes mellitus	3.39e-05	0.000175	CcSEcCtD
Fentanyl—Dizziness—Irbesartan—type 2 diabetes mellitus	3.37e-05	0.000175	CcSEcCtD
Fentanyl—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	3.37e-05	0.000174	CcSEcCtD
Fentanyl—Methadone—CYP3A4—type 2 diabetes mellitus	3.35e-05	0.00896	CrCbGaD
Fentanyl—Diarrhoea—Losartan—type 2 diabetes mellitus	3.28e-05	0.00017	CcSEcCtD
Fentanyl—Urticaria—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000169	CcSEcCtD
Fentanyl—Body temperature increased—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000169	CcSEcCtD
Fentanyl—Abdominal pain—Ramipril—type 2 diabetes mellitus	3.25e-05	0.000169	CcSEcCtD
Fentanyl—Vomiting—Irbesartan—type 2 diabetes mellitus	3.24e-05	0.000168	CcSEcCtD
Fentanyl—Rash—Irbesartan—type 2 diabetes mellitus	3.22e-05	0.000167	CcSEcCtD
Fentanyl—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.21e-05	0.000166	CcSEcCtD
Fentanyl—Nausea—Metformin—type 2 diabetes mellitus	3.21e-05	0.000166	CcSEcCtD
Fentanyl—Headache—Irbesartan—type 2 diabetes mellitus	3.2e-05	0.000165	CcSEcCtD
Fentanyl—Dizziness—Losartan—type 2 diabetes mellitus	3.17e-05	0.000164	CcSEcCtD
Fentanyl—Vomiting—Losartan—type 2 diabetes mellitus	3.05e-05	0.000158	CcSEcCtD
Fentanyl—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000157	CcSEcCtD
Fentanyl—Nausea—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000157	CcSEcCtD
Fentanyl—Rash—Losartan—type 2 diabetes mellitus	3.03e-05	0.000157	CcSEcCtD
Fentanyl—Dermatitis—Losartan—type 2 diabetes mellitus	3.02e-05	0.000157	CcSEcCtD
Fentanyl—Headache—Losartan—type 2 diabetes mellitus	3.01e-05	0.000156	CcSEcCtD
Fentanyl—Asthenia—Ramipril—type 2 diabetes mellitus	2.95e-05	0.000153	CcSEcCtD
Fentanyl—Pruritus—Ramipril—type 2 diabetes mellitus	2.91e-05	0.000151	CcSEcCtD
Fentanyl—Nausea—Losartan—type 2 diabetes mellitus	2.85e-05	0.000148	CcSEcCtD
Fentanyl—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.82e-05	0.000146	CcSEcCtD
Fentanyl—Dizziness—Ramipril—type 2 diabetes mellitus	2.72e-05	0.000141	CcSEcCtD
Fentanyl—Vomiting—Ramipril—type 2 diabetes mellitus	2.62e-05	0.000136	CcSEcCtD
Fentanyl—Rash—Ramipril—type 2 diabetes mellitus	2.6e-05	0.000134	CcSEcCtD
Fentanyl—Dermatitis—Ramipril—type 2 diabetes mellitus	2.59e-05	0.000134	CcSEcCtD
Fentanyl—Headache—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000134	CcSEcCtD
Fentanyl—Nausea—Ramipril—type 2 diabetes mellitus	2.45e-05	0.000127	CcSEcCtD
Fentanyl—OPRK1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.68e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.66e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AGT—type 2 diabetes mellitus	7.65e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.65e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.65e-06	0.000145	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.63e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	7.61e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	7.59e-06	0.000144	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	7.56e-06	0.000144	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	7.56e-06	0.000144	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.52e-06	0.000143	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.5e-06	0.000143	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.5e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.5e-06	0.000142	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	7.47e-06	0.000142	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	7.47e-06	0.000142	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.46e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.41e-06	0.000141	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.4e-06	0.000141	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	7.39e-06	0.00014	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—INS—type 2 diabetes mellitus	7.3e-06	0.000139	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	7.3e-06	0.000139	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	7.29e-06	0.000138	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.28e-06	0.000138	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.19e-06	0.000137	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	7.16e-06	0.000136	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	7.16e-06	0.000136	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	7.13e-06	0.000136	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	7.13e-06	0.000136	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	7.11e-06	0.000135	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	7.11e-06	0.000135	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	7.11e-06	0.000135	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.09e-06	0.000135	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.07e-06	0.000134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.07e-06	0.000134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.06e-06	0.000134	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.03e-06	0.000134	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	7e-06	0.000133	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.99e-06	0.000133	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	6.97e-06	0.000132	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.95e-06	0.000132	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.95e-06	0.000132	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.95e-06	0.000132	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.91e-06	0.000131	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	6.87e-06	0.00013	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.82e-06	0.00013	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.82e-06	0.00013	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	6.81e-06	0.000129	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.78e-06	0.000129	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.71e-06	0.000127	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.71e-06	0.000127	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.69e-06	0.000127	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	6.65e-06	0.000126	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.58e-06	0.000125	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.56e-06	0.000125	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.56e-06	0.000125	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.54e-06	0.000124	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.52e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.49e-06	0.000123	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.48e-06	0.000123	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	6.47e-06	0.000123	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.45e-06	0.000123	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	6.44e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.41e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.41e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INS—type 2 diabetes mellitus	6.41e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.36e-06	0.000121	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.34e-06	0.00012	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.34e-06	0.00012	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.34e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	6.34e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	6.34e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.3e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.26e-06	0.000119	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	6.23e-06	0.000118	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	6.23e-06	0.000118	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	6.23e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.2e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.19e-06	0.000118	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	6.17e-06	0.000117	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.17e-06	0.000117	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.16e-06	0.000117	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	6.15e-06	0.000117	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	6.12e-06	0.000116	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	6.06e-06	0.000115	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	6.06e-06	0.000115	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.03e-06	0.000115	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	5.98e-06	0.000114	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.96e-06	0.000113	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.94e-06	0.000113	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.93e-06	0.000113	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.89e-06	0.000112	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.88e-06	0.000112	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.73e-06	0.000109	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.7e-06	0.000108	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	5.68e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.65e-06	0.000107	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.64e-06	0.000107	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.64e-06	0.000107	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.62e-06	0.000107	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.62e-06	0.000107	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.62e-06	0.000107	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.58e-06	0.000106	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.57e-06	0.000106	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.5e-06	0.000105	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.5e-06	0.000104	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.49e-06	0.000104	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.48e-06	0.000104	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.44e-06	0.000103	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.41e-06	0.000103	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.4e-06	0.000103	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.4e-06	0.000103	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.4e-06	0.000103	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.39e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.39e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.39e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.39e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.34e-06	0.000101	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.33e-06	0.000101	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.29e-06	0.0001	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.27e-06	0.0001	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.24e-06	9.95e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.23e-06	9.94e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.21e-06	9.9e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.17e-06	9.82e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.14e-06	9.76e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	5.1e-06	9.7e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.08e-06	9.66e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	5.06e-06	9.61e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.98e-06	9.47e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.97e-06	9.45e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.96e-06	9.43e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.88e-06	9.28e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.88e-06	9.28e-05	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.81e-06	9.14e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.81e-06	9.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.8e-06	9.13e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.77e-06	9.06e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.75e-06	9.02e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.75e-06	9.02e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.74e-06	9e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.74e-06	9e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.73e-06	8.98e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.71e-06	8.95e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.66e-06	8.85e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.66e-06	8.85e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.66e-06	8.85e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.64e-06	8.81e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.61e-06	8.77e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.58e-06	8.69e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.51e-06	8.56e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.49e-06	8.52e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.47e-06	8.49e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.47e-06	8.48e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.46e-06	8.47e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.44e-06	8.44e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.39e-06	8.35e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.39e-06	8.35e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.37e-06	8.3e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.32e-06	8.21e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.31e-06	8.19e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.28e-06	8.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.28e-06	8.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.28e-06	8.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.26e-06	8.09e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.24e-06	8.06e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.24e-06	8.05e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.18e-06	7.94e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.15e-06	7.89e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.15e-06	7.89e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	4.15e-06	7.89e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	4.14e-06	7.86e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.13e-06	7.85e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	4.1e-06	7.8e-05	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.07e-06	7.73e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.05e-06	7.69e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.03e-06	7.66e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	4.03e-06	7.66e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	4.02e-06	7.65e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4e-06	7.61e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.98e-06	7.56e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.84e-06	7.3e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.84e-06	7.3e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.84e-06	7.3e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.82e-06	7.26e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.81e-06	7.24e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.77e-06	7.16e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.77e-06	7.16e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.75e-06	7.12e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.74e-06	7.1e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.71e-06	7.06e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.69e-06	7.02e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.69e-06	7.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.66e-06	6.95e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.64e-06	6.92e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.63e-06	6.89e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.57e-06	6.78e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.56e-06	6.75e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.53e-06	6.71e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.53e-06	6.71e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.51e-06	6.68e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.51e-06	6.67e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.51e-06	6.67e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.47e-06	6.6e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.47e-06	6.6e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.42e-06	6.5e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.33e-06	6.33e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.33e-06	6.33e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.23e-06	6.13e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.19e-06	6.06e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.14e-06	5.96e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	3.1e-06	5.88e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.08e-06	5.85e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INS—type 2 diabetes mellitus	3.04e-06	5.77e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.94e-06	5.59e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.87e-06	5.45e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.87e-06	5.45e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.86e-06	5.43e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.82e-06	5.36e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.8e-06	5.32e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.78e-06	5.29e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.74e-06	5.2e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.66e-06	5.06e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.66e-06	5.06e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.66e-06	5.06e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.61e-06	4.96e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.58e-06	4.91e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.56e-06	4.86e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.55e-06	4.84e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.48e-06	4.72e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.45e-06	4.66e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.44e-06	4.63e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.37e-06	4.49e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.35e-06	4.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.31e-06	4.39e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.24e-06	4.26e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.24e-06	4.25e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.2e-06	4.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.19e-06	4.16e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.18e-06	4.15e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.17e-06	4.11e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.91e-06	3.62e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.87e-06	3.56e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.72e-06	3.26e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.64e-06	3.12e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.64e-06	3.12e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.62e-06	3.08e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.5e-06	2.85e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	2.33e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.54e-07	1.43e-05	CbGpPWpGaD
